Verso Capital has acquired a majority stake in Vetrospace to facilitate its international growth and expand its product offerings in the market for safe and productive workspaces.

Target Information

Vetrospace is an innovative company specializing in the design of virus-free modular workspaces tailored for both office and healthcare environments. The company's unique offerings incorporate patented technology that effectively eliminates 99.9% of harmful viruses, microbes, and airborne particles, thus addressing the heightened demand for safe working conditions in the wake of the global pandemic. Vetrospace’s ISO-7 cleanroom certified meeting rooms maintain a controlled microenvironment, enhancing safety while boosting productivity through superior air quality and sound isolation.

Founded by Jouko Urpolahti, Vetrospace has developed a product line that emphasizes all-day usability through advanced soundproofing and a consistent supply of fresh air. The efficiency of Vetrospace's solutions has been validated by VTT Technical Research Centre of Finland, affirming their effectiveness in reducing harmful pathogens and pollutants. The company's clientele spans Europe and the U.S., including prominent institutions such as leading investment banks and major hospitals.

Industry Overview

The demand for safe and productive workspaces has significantly increased in Finland and globally due to the COVID-19 pandemic, prompting organizations to re-evaluate their workplace environments. Companies are investing heavil